Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases

NCT00156975 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

384

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms
Liver Metastases

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Arbeitsgruppe Lebermetastasen und Tumoren